Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,503,000 | 2,819,000 | 7,013,000 | 5,511,000 | 6,660,000 |
| Marketable Securities | 1,907,000 | 1,921,000 | 5,029,000 | 6,248,000 | 3,480,000 |
| Receivables | 2,064,000 | 1,991,000 | 1,921,000 | 1,816,000 | 1,729,000 |
| Inventories | 555,000 | 536,000 | 541,000 | 537,000 | 533,000 |
| Other current assets | 824,000 | 605,000 | 388,000 | 671,000 | 734,000 |
| TOTAL | $6,853,000 | $7,872,000 | $14,892,000 | $14,783,000 | $13,136,000 |
| Non-Current Assets | |||||
| PPE Net | 1,292,000 | 1,251,000 | 1,070,000 | 1,002,000 | 989,000 |
| Intangibles | 24,474,000 | 24,617,000 | 13,302,000 | 15,003,000 | 15,084,000 |
| Other Non-Current Assets | 825,000 | 816,000 | 877,000 | 948,000 | 1,097,000 |
| TOTAL | $26,591,000 | $26,684,000 | $15,249,000 | $16,953,000 | $17,170,000 |
| Total Assets | $33,444,000 | $34,556,000 | $30,141,000 | $31,736,000 | $30,306,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,497,000 | N/A | N/A | 1,400,000 | 500,000 |
| Accounts payable and accrued liabilities | 294,000 | 320,000 | 305,000 | 263,000 | 272,000 |
| Accrued Expenses | 2,615,000 | 2,672,000 | 2,523,000 | 2,265,000 | 2,379,000 |
| TOTAL | $4,502,000 | $3,115,000 | $2,987,000 | $4,049,000 | $3,240,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,754,000 | 20,271,000 | 15,838,000 | 12,874,000 | 13,783,000 |
| Deferred Revenues | 64,000 | 69,000 | 75,000 | 66,000 | 57,000 |
| Other Non-Current Liabilities | 2,924,000 | 3,186,000 | 3,034,000 | 2,398,000 | 2,288,000 |
| TOTAL | $25,512,000 | $26,269,000 | $20,233,000 | $17,837,000 | $18,621,000 |
| Total Liabilities | $30,014,000 | $29,384,000 | $23,220,000 | $21,886,000 | $21,861,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 703,363 | 724,827 | 752,176 | 787,317 | 782,351 |
| Common Shares | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 |
| Retained earnings | 15,404,000 | 14,359,000 | 13,061,000 | 13,142,000 | 12,093,000 |
| Other shareholders' equity | -119,000 | -328,000 | 287,000 | 337,000 | 237,000 |
| TOTAL | $3,430,000 | $5,172,000 | $6,921,000 | $9,850,000 | $8,445,000 |
| Total Liabilities And Equity | $33,444,000 | $34,556,000 | $30,141,000 | $31,736,000 | $30,306,000 |